Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
43
CFNB Quote, Financials, Valuation and Earnings
Last price:
$18.80
Seasonality move
:
1.47%
Day range:
$18.80 - $19.50
52-week range:
$18.26 - $25.00
Dividend yield:
0%
P/E ratio:
5.36x
P/S ratio:
3.87x
P/B ratio:
0.69x
Volume:
--
Avg. volume:
613
1-year change:
-5.53%
Market cap:
$175M
Revenue:
$49.2M
EPS (TTM):
$3.51
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5M | $46.3M | -$16.3M | $23.1M | $49.2M | |
| Revenue Growth (YoY) | -88.85% | 2972.58% | -- | -- | 113.21% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.4M | $4.1M | $2.9M | $2.7M | $2.6M | |
| Other Inc / (Exp) | -$9.9M | $41.1M | -$23.5M | $14M | $41.4M | |
| Operating Expenses | $8.6M | $8.9M | $3.2M | $4.2M | $2.7M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$290K | $47.1M | -$18.8M | $21.9M | $46.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.1M | $10.9M | -$6.1M | $5.1M | $13M | |
| Net Income to Company | -$2.4M | $36.2M | -$12.7M | $16.9M | $33.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$2.4M | $36.2M | -$12.7M | $16.9M | $33.6M | |
| Basic EPS (Cont. Ops) | -$0.23 | $3.52 | -$1.23 | $1.69 | $3.54 | |
| Diluted EPS (Cont. Ops) | -$0.23 | $3.52 | -$1.23 | $1.69 | $3.54 | |
| Weighted Average Basic Share | $10.3M | $10.3M | $10.3M | $10M | $9.5M | |
| Weighted Average Diluted Share | $10.3M | $10.3M | $10.3M | $10M | $9.5M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$290K | $47.1M | -$18.8M | $21.9M | $46.6M | |
| Revenue (Reported) | $1.5M | $46.3M | -$16.3M | $23.1M | $49.2M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$290K | $47.1M | -$18.8M | $21.9M | $46.6M | |
| Period Ending | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -$4.8M | $12.4M | $18.8M | $23.2M | $15.5M | |
| Revenue Growth (YoY) | -- | -- | 50.8% | 23.43% | -10.89% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.4M | $1M | $892K | $553K | -- | |
| Other Inc / (Exp) | -$8.4M | $9.6M | $17M | $21.3M | -- | |
| Operating Expenses | $2.1M | $1.2M | $966K | $683K | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$5.6M | $11.6M | $17.9M | $22.6M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.8M | $3.2M | $2.8M | $6.3M | -- | |
| Net Income to Company | -$3.9M | $8.5M | $15.1M | $16.3M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$3.9M | $8.5M | $15.1M | $16.3M | -- | |
| Basic EPS (Cont. Ops) | -$0.38 | $0.82 | $1.47 | $1.58 | -- | |
| Diluted EPS (Cont. Ops) | -$0.38 | $0.82 | $1.47 | $1.58 | -- | |
| Weighted Average Basic Share | $10.3M | $10.3M | $10.3M | $10.3M | -- | |
| Weighted Average Diluted Share | $10.3M | $10.3M | $10.3M | $10.3M | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -$5.2M | $11.8M | $18M | $22.6M | -- | |
| Revenue (Reported) | -$4.8M | $12.4M | $18.8M | $23.2M | $15.5M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -$5.2M | $11.8M | $18M | $22.6M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.8M | $42.2M | $40.3M | $33.4M | $45.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $2.7M | $2.7M | |
| Other Inc / (Exp) | -- | -- | $831K | $24.9M | $38.1M | |
| Operating Expenses | -- | -- | -- | $4.1M | $5.4M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | $32.1M | $45.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $8.1M | $12.3M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | $24M | $32.9M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | $2.45 | $3.51 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | $2.45 | $3.51 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | $8.8M | $42.2M | $40.3M | $33.4M | $45.2M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $153.1M | $37M | $53.8M | $43.1M | $24.7M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $203.8M | $75.9M | $77.8M | $60.1M | $34.2M | |
| Property Plant And Equipment | $4.9M | $1.8M | $3.2M | $1.3M | $1.2M | |
| Long-Term Investments | $51.3M | $160.1M | $131.6M | $163.7M | $223.6M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $267.8M | $242.9M | $216.5M | $227.4M | $261M | |
| Accounts Payable | $3.3M | $628K | $954K | $1.7M | $36K | |
| Accrued Expenses | $2.1M | $1.3M | $829K | $592K | $412K | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $5.4M | $1.9M | $1.8M | $2.3M | $448K | |
| Long-Term Debt | $1.9M | $1.2M | $515K | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $68.1M | $12.6M | $4.6M | $8.1M | $18.4M | |
| Common Stock | $103K | $103K | $103K | $97K | $93K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $199.6M | $230.3M | $211.9M | $219.4M | $242.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $199.6M | $230.3M | $211.9M | $219.4M | $242.7M | |
| Total Liabilities and Equity | $267.8M | $242.9M | $216.5M | $227.4M | $261M | |
| Cash and Short Terms | $153.1M | $37M | $53.8M | $43.1M | $24.7M | |
| Total Debt | $1.9M | $1.2M | $515K | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $98.9M | $12.6M | $43.1M | $30M | $21.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $207K | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $99.9M | $43.9M | $63.5M | $41.7M | $29.2M | |
| Property Plant And Equipment | $624K | $1.9M | $791K | $1.4M | $787K | |
| Long-Term Investments | $108.1M | $201.3M | $143.9M | $188.1M | $242.5M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $263.9M | $252.3M | $212.5M | $233.3M | $274.4M | |
| Accounts Payable | $1.3M | $2.6M | $2.4M | $79K | $22K | |
| Accrued Expenses | $1.4M | $1M | $906K | $559K | $881K | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2.7M | $3.6M | $3.3M | $638K | $903K | |
| Long-Term Debt | $1.6M | $871K | $158K | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $53.3M | $17.2M | $6.6M | $9.9M | $21.9M | |
| Common Stock | $103K | $103K | $97K | $93K | $93K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $210.6M | $235.1M | $205.9M | $223.3M | $252.5M | |
| Total Liabilities and Equity | $263.9M | $252.3M | $212.5M | $233.3M | $274.4M | |
| Cash and Short Terms | $98.9M | $12.6M | $43.1M | $30M | $21.6M | |
| Total Debt | -- | -- | $158K | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$2.4M | $36.2M | -$12.7M | $16.9M | $33.6M | |
| Depreciation & Amoritzation | $489K | $111K | $74K | $48K | $95K | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$120K | -$2.5M | $788K | $1.8M | $39K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $22.5M | -$4.4M | $3.3M | $7.1M | $3.9M | |
| Capital Expenditures | -- | $30.9M | $7.1M | $11.1M | $6.6M | |
| Cash Acquisitions | -- | $4.5M | -- | -- | -- | |
| Cash From Investing | $98.1M | -$49.2M | $19.3M | -$8.5M | -$12M | |
| Dividends Paid (Ex Special Dividend) | -$5.3M | -$5.6M | -$5.8M | -- | -$3.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$9.4M | -$6.6M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$36.3M | -$62.4M | -$5.8M | -$9.4M | -$10.3M | |
| Beginning Cash (CF) | $68.8M | $153.1M | $37M | $53.8M | $43.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $84.2M | -$116M | $16.8M | -$10.7M | -$18.4M | |
| Ending Cash (CF) | $153.1M | $37M | $53.8M | $43.1M | $24.7M | |
| Levered Free Cash Flow | $22.5M | -$35.3M | -$3.8M | -$4M | -$2.7M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.3M | -- | -- | -- | -- | |
| Depreciation & Amoritzation | $14K | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$2.5M | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$5.3M | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | $2M | -- | -- | -- | -- | |
| Cash From Investing | -$41.6M | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$1K | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$1K | -- | -- | -- | -- | |
| Beginning Cash (CF) | $84M | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$46.9M | -- | -- | -- | -- | |
| Ending Cash (CF) | $37M | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $109.8M | $70.3M | $64.1M | $4.3M | -$2.9M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2026-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $10.5M | -- | -- | -- | -- | |
| Depreciation & Amoritzation | $24K | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $355K | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.6M | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$20.3M | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$5.8M | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$5.8M | -- | -- | -- | -- | |
| Beginning Cash (CF) | $67.9M | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$24.4M | -- | -- | -- | -- | |
| Ending Cash (CF) | $43.4M | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get CFNB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CFNB
Sector
P/E ratio
5.36x
12.18x
PEG ratio
--
0.40x
P/B ratio
0.69x
1.10x
Price / LTM sales
3.87x
2.66x
Growth Metrics
CFNB
Sector
Revenue growth
--
5.1%
Earnings growth
--
2.61%
Revenue (5-year growth)
29.49%
5.17%
Earnings forecast
--
$0.61
Profitability
CFNB
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
13.72%
5.2%
Return on assets
12.83%
0.97%
Return on equity
13.72%
9.24%
Earnings Date
Last Earnings Date
Jan
31
Next Earnings Date
Oct
24
Estimated Next Earnings Date
May
2
Balance Sheet
CFNB
Sector
Total cash
$21.6M
$452M
Short term investments
--
$220.9M
Total assets
$261M
$3.8B
Long term debt
--
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
72
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
